[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100578130":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":25,"centralContacts":29,"locations":37,"responsibleParty":58,"collaborators":18,"id":60,"slug":61,"hasResults":62,"nctId":63,"briefTitle":64,"officialTitle":64,"acronym":18,"eligibilityCriteria":65,"healthyVolunteers":62,"sex":66,"minAge":67,"maxAge":18,"enrollmentInfo":68,"targetDuration":18,"studyType":71,"phases":72,"briefSummary":74,"conditions":75,"keywords":80,"overallStatus":39,"whyStopped":18,"lastUpdateSubmitDate":93,"lastUpdatePostDateStruct":94,"startDateStruct":97,"completionDateStruct":99,"leadSponsor":101,"locationsCount":102},{"fullName":5,"class":6},"Dana-Farber Cancer Institute","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Arm A: Tai Chi Treatment Group","EXPERIMENTAL","14 randomized participants will complete:\n\n* 1 baseline visit session.\n* Virtual Tai Chi session 2x weekly (60 minutes per session).\n* Independent Tai Chi sessions 3 days a week (60 minutes per session).\n* 12 week follow up visit.",[13],"Behavioral: Tai Chi Program",{"label":15,"type":16,"description":17,"interventionNames":18},"Arm B: Waitlist Control Group","NO_INTERVENTION","7 randomized participants will complete:\n\n* 1 baseline visit session\n* Standard CIPN care prescribed by primary care physician\u002Foncologist.\n* 12 week follow up visit\n* Participants will be offered 24 complimentary, virtual, Tai Chi training sessions over 12 weeks after completion of the 12-week follow-up visit.",null,[20],{"type":21,"name":22,"description":23,"armGroupLabels":24,"otherNames":18},"BEHAVIORAL","Tai Chi Program","12-week virtual Tai Chi program with experienced Tai Chi instructor. Sessions will be conducted via the HIPPA-compliant teleconference platform, Zoom.",[9],[26],{"name":27,"affiliation":5,"role":28},"Ting Bao, MD","PRINCIPAL_INVESTIGATOR",[30,34],{"name":27,"role":31,"phone":32,"phoneExt":18,"email":33},"CONTACT","857-215-2844","ting_bao@dfci.harvard.edu",{"name":35,"role":31,"phone":18,"phoneExt":18,"email":36},"Natalie Viyaran","natalie_viyaran@dfci.harvard.edu",[38],{"facility":5,"status":39,"city":40,"state":41,"zip":42,"country":43,"countryCode":44,"cosmosGeoPoint":45,"geoPoint":50,"contacts":51},"RECRUITING","Boston","Massachusetts","02215","United States","US",{"type":46,"coordinates":47},"Point",[48,49],-71.05977,42.35843,{"lat":49,"lon":48},[52,53,57],{"name":27,"role":31,"phone":32,"phoneExt":18,"email":33},{"name":54,"role":31,"phone":55,"phoneExt":18,"email":56},"Peter Wayne, PhD","617-732-6271","pwayne@bwh.harvard.edu",{"name":27,"role":28,"phone":18,"phoneExt":18,"email":18},{"type":28,"investigatorFullName":27,"investigatorTitle":59,"investigatorAffiliation":5,"oldNameTitle":18,"oldOrganization":18},"Principle Investigator","100578130","feasibility-testing-of-a-tai-chi-program-for-chemotherapy-induced-peripheral-neuropathy-treatment-tct-100578130",false,"NCT06807294","Feasibility Testing of a Tai Chi Program for Chemotherapy-Induced Peripheral Neuropathy Treatment (TCT)","Inclusion Criteria:\n\n* Age 18 years old and older\n* Cancer survivors with no evidence of disease (cancer);\n* Completed neurotoxic chemotherapy, i.e., platinum agents, taxanes, vinca alkaloids, and bortezomib, at least three months before enrollment;\n* A CIPN diagnosis based on symptom history, loss of deep tendon reflexes, or presence of symmetrical stocking-glove pain, numbness, or paresthesia;\n* Answers \"yes\" to the following question: \"Do you feel as though your balance is affected from experiencing CIPN?\" or \"Are you afraid of falling as a result of your CIPN?\";\n* On a stable regimen (no change in past three months) if taking anti-neuropathy or other pain medications;\n* Eastern Cooperative Oncology Group (ECOG) Performance Status Scale score ≤ 2\n* Willing to adhere to all study-related procedures, including randomization to the Tai Chi or waitlist group, 2 in-person visits to Dana-Farber Cancer Institute (DFCI) (one within 2 weeks of enrollment and one at week 12);\n* Willing to adhere to requirement that no new pain medication be taken throughout the study period; and\n* Individuals receiving endocrine therapy or targeted\u002Fantibody therapy, such as trastuzumab, pertuzumab, or immunotherapy, will be eligible to participate.\n\nExclusion Criteria:\n\n• Patients who have received physical therapy or Tai Chi training, specifically for CIPN, in the past three months.","ALL","18 Years",{"count":69,"type":70},21,"ESTIMATED","INTERVENTIONAL",[73],"NA","This research is being done to determine whether a 12-week virtual Tai Chi training program, designed to improve balance and small nerve fiber function, is feasible and acceptable among cancer survivors with chemotherapy-induced peripheral neuropathy (CIPN).",[76,77,78,79],"Chemotherapy Induced Peripheral Neuropathy (CIPN)","Peripheral Neuropathy Due to Chemotherapy","Peripheral Neuropathies","Neuropathy",[81,82,83,84,85,86,87,88,89,90,91,92],"Peripheral Neuropathy","Chemotherapy Induced Peripheral Neuropathy","Cancer survivor","CIPN","Tai Chi","Balance training","Falls prevention","Non-pharmacological intervention","Mind-body exercise","Quality of life","Feasibility study","Pilot study","2026-01-27",{"date":95,"type":96},"2026-01-29","ACTUAL",{"date":98,"type":96},"2026-01-16",{"date":100,"type":70},"2026-10-31",{"name":5,"class":6},1]